Summit Therapeutics Inc. Common Stock (SMMT)

Typically moves ±10.27% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-10-23 APPROXIMATE

Across 22 earnings reports since May 17, 2021, Summit Therapeutics Inc. Common Stock (SMMT) has a clear post-earnings pattern. It moves ±10.27% on average after reporting and finishes higher 36.4% of the time. Its largest post-earnings gain was +18.78% (May 01, 2024) and its largest decline was -26.09% (Feb 20, 2024). The next earnings report is predicted for 2026-10-23 (approximate).

Earnings reactions

How SMMT moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±10.27%

Positive %

36.4%

Negative %

63.6%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Jul 23, 2026	☽ POST	-8.59%	open_in_new
Apr 30, 2026	☽ POST	-24.92%	open_in_new
Feb 23, 2026	☽ POST	+0%	open_in_new
Oct 20, 2025	☀ PRE	-4.71%	open_in_new
Aug 11, 2025	☽ POST	-9.07%	open_in_new
May 01, 2025	☽ POST	+13.34%	open_in_new
Feb 24, 2025	☀ PRE	-14.7%	open_in_new
Oct 30, 2024	☀ PRE	-14.58%	open_in_new
Aug 06, 2024	☀ PRE	-4.93%	open_in_new
May 01, 2024	☀ PRE	+18.78%	open_in_new
Feb 20, 2024	☀ PRE	-26.09%	open_in_new
Nov 07, 2023	☀ PRE	-12.16%	open_in_new
Aug 09, 2023	☀ PRE	+11.82%	open_in_new
May 11, 2023	☽ POST	-10.13%	open_in_new
Mar 09, 2023	☽ POST	+5.3%	open_in_new
Nov 09, 2022	☽ POST	-3.86%	open_in_new
Aug 11, 2022	☽ POST	-1.83%	open_in_new
May 11, 2022	☽ POST	+16.1%	open_in_new
Mar 17, 2022	☽ POST	+0.32%	open_in_new
Nov 15, 2021	☀ PRE	-3.61%	open_in_new
Aug 11, 2021	☀ PRE	-3.69%	open_in_new
May 17, 2021	☽ POST	+17.32%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±10.27%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 26 →

Funds holding

$502464588

Total value held

Buying

21 added · 5 reduced

State Street Corp

$138951118 +35.69%

Blackrock, Inc.

$138838127 -1.29%

Ubs Group Ag

$77311305 NEW BUY

Goldman Sachs Group Inc

$65760228 +1352.52%

Morgan Stanley

$21126777 -12.15%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
8-K	20260903	open_in_new SEC.gov
8-K	20260826	open_in_new SEC.gov
8-K	20260805	open_in_new SEC.gov
10-Q	20260723	open_in_new SEC.gov
424B5	20260723	open_in_new SEC.gov
8-K	20260723	open_in_new SEC.gov
8-K	20260723	open_in_new SEC.gov
8-K	20260722	open_in_new SEC.gov
4	20260612	open_in_new SEC.gov
4	20260612	open_in_new SEC.gov

Frequently asked about SMMT earnings

When does Summit Therapeutics Inc. Common Stock report earnings next? expand_more

Summit Therapeutics Inc. Common Stock (SMMT)'s next earnings date is approximate for 2026-10-23. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does SMMT stock move after earnings? expand_more

Over 22 reports, SMMT has moved an average of ±10.27% the session after earnings, closing higher 36.4% of the time.

What was SMMT's biggest post-earnings move? expand_more

SMMT's largest post-earnings gain on record was +18.78% on May 01, 2024, and its largest decline was -26.09% on Feb 20, 2024.

Where can I find Summit Therapeutics Inc. Common Stock's SEC filings? expand_more

All of Summit Therapeutics Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.